Detroit, MI

Upcoming
Navigating Bispecific Antibodies for Multiple Myeloma: Best Practices and Clinical Implementation
November 19, 2024
5:30 pm
Identify unmet needs and recent trends in the management of patients with relapsed/refractory multiple myeloma (R/R MM) receiving bispecific antibody therapies.